Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 4976 - 5000 of 11848 in total
Pegamotecan has been used in trials studying the treatment of Cancer of Stomach, Sarcoma, Soft Tissue, and Gastroesophageal Cancer.
Investigational
Matched Categories: … Compounds used in a research, industrial, or household setting …
Deoxyspergualin has been used in trials studying the treatment of Lupus Nephritis, Chronic Rejection, and Diabetes Mellitus, Type 1.
Investigational
Matched Categories: … Compounds used in a research, industrial, or household setting …
SHR-A1904 is under investigation in clinical trial NCT04877717 (A Study of SHR-A1904 in Patients With Advanced Solid Cancer).
Investigational
Matched Description: … SHR-A1904 is under investigation in clinical trial NCT04877717 (A Study of SHR-A1904 in Patients With …
8-azaguanine is one of the early purine analogs showing antineoplastic activity. It functions as an antimetabolite and is easily incorporated into ribonucleic acids.
Experimental
A purine base found in most body tissues and fluids, certain plants, and some urinary calculi. It is an intermediate in the degradation of adenosine monophosphate to uric acid, being formed by oxidation of hypoxanthine. The methylated xanthine compounds caffeine, theobromine, and theophylline and their derivatives are used in medicine...
Experimental
Matched Description: … A purine base found in most body tissues and fluids, certain plants, and some urinary calculi. …
Experimental
Experimental
Experimental
Experimental
Ginsenoside B2 is under investigation in clinical trial NCT00781534 (A Clinical Trial of Ginseng in Diabetes).
Investigational
Matched Iupac: … -5-en-2-yl)-hexadecahydro-1H-cyclopenta[a]phenanthren-5-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3 ... 6,6,9a-pentamethyl-1-(6-methyl-2-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hept
Matched Description: … Ginsenoside B2 is under investigation in clinical trial NCT00781534 (A Clinical Trial of Ginseng in Diabetes …
Mavorixafor is a small molecule drug candidate that belongs to a new investigational class of anti-HIV drugs known as entry (fusion) inhibitors. Currently there is only one FDA-approved entry inhibitor, enfuvirtide (Fuzeon), that is available for the treatment of HIV infection. Several experimental entry inhibitors are now in early stage...
Investigational
Matched Description: … Mavorixafor is a small molecule drug candidate that belongs to a new investigational class of anti-HIV ... Mavorixafor is a selective allosteric antagonist of the CXCR4 receptor on HIV, preventing the virus from …
Experimental
Investigational
Lesogaberan has been used in trials studying the treatment and basic science of GERD, Reflux, Heartburn, Regurgitation, and Reflux Disease, among others.
Investigational
Matched Categories: … GABA-A Receptor Agonists …
Hydroxytyrosol has been used in trials studying the prevention of Breast Cancer.
Investigational
Matched Categories: … Compounds used in a research, industrial, or household setting …
A liquid that functions as a strong oxidizing agent. It has an acrid odor and is used as a disinfectant.
Experimental
Matched Description: … A liquid that functions as a strong oxidizing agent. ... It has an acrid odor and is used as a disinfectant. …
Matched Categories: … Compounds used in a research, industrial, or household setting …
Citrulline is an amino acid. It is made from ornithine and carbamoyl phosphate in one of the central reactions in the urea cycle. It is also produced from arginine as a by-product of the reaction catalyzed by NOS family. Its name is derived from citrullus, the Latin word for watermelon,...
Investigational
Nutraceutical
Matched Description: … It is also produced from arginine as a by-product of the reaction catalyzed by NOS family. …
Amidinopenicillanic acid derivative with broad spectrum antibacterial action. It is poorly absorbed if given orally and is used in urinary infections and typhus. Amdinocillin is not available in the United States.
Investigational
Withdrawn
Investigational
AT7519 is a selective inhibitor of certain Cyclin Dependent Kinases (CDKs) leading to tumour regression. It is developed by Astex for the treatment of solid tumours and haematological malignancies.
Investigational
Matched Description: … AT7519 is a selective inhibitor of certain Cyclin Dependent Kinases (CDKs) leading to tumour regression …
Displaying drugs 4976 - 5000 of 11848 in total